Thrombin-Activatable Fibrinolysis Inhibitor and Cardiovascular Risk Factors in Polycystic Ovary Syndrome - Erdoğan, M; Karadeniz, M; Alper, G E; Tamsel, S; Uluer, H; Çağlayan, O; Saygılı, F; Yılmaz, C (Experimental and Clinical Endocrinology & Diabetes, 2008)